Onderneming Advanced Oncotherapy plc
Aandelen
AVO
GB00BD6SX109
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,925 GBX | -.--% | +10,00% | +10,00% |
03/05 | Financieringsgesprekken Advanced Oncotherapy gaan door, fondsen vertraagd | AN |
02/04 | Sareum verhoogt bod op detailhandel; SThree haalt voormalig ITV-directeur binnen | AN |
Vakgebied
Aantal werknemers: 174
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 27-08-14 | |
Director of Finance/CFO | - | 01-10-16 | |
Michael Sinclair
CHM | Chairman | 82 | 16-06-06 |
Jonathan Farr
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-17 |
Ed Lee
COO | Chief Operating Officer | - | 01-02-17 |
David Navas
IRC | Investor Relations Contact | - | - |
Henry Clarke
SEC | Corporate Secretary | - | 19-05-19 |
Bridget Biggar
HRO | Human Resources Officer | - | 01-11-16 |
Graham Pughe
AUD | Comptroller/Controller/Auditor | - | 01-12-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 29-09-20 |
Michael Sinclair
CHM | Chairman | 82 | 16-06-06 |
Hans von Celsing
BRD | Director/Board Member | 74 | 26-01-17 |
Director/Board Member | 73 | 01-10-13 | |
Ren Hua Zhang
BRD | Director/Board Member | 58 | 28-08-18 |
Director/Board Member | 72 | 26-04-13 | |
Director/Board Member | 74 | 09-02-17 | |
Chief Executive Officer | 49 | 27-08-14 | |
Stephen Myers
BRD | Director/Board Member | 78 | 26-01-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 542 573 869 | 284 689 154 ( 52,47 %) | 0 | 52,47 % |
Bedrijfsgegevens
Advanced Oncotherapy Plc
4 Tenterden Street Third Floor
W1S 1TE, London
+44 20 3617 8728
http://advancedoncotherapy.comSector
Verkoop per regio
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,00% | 11,92 mln. | |
+7,84% | 218 mld. | |
+7,35% | 184 mld. | |
+13,04% | 135 mld. | |
+26,03% | 107 mld. | |
-1,33% | 62,38 mld. | |
+11,80% | 51,37 mld. | |
+4,81% | 50,9 mld. | |
+0,30% | 40,87 mld. | |
+2,78% | 36,28 mld. |